GAS6 and leukemia: Our findings are consistent with the recent report showing that Gas6/AXL signaling stabilizes β‐catenin protein in an AKT‐dependent mechanism, thereby regulating self‐renewal of drug‐resistant leukemia stem cells (Jin et al., 2016).